Clinical Trial Update: Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating futibatinib in combination with chemotherapy and immunotherapy for colorectal cancer; trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Futibatinib (futibatinib)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING